INVESTORS
NEWSROOM
Responsibility
CONSUMERS
HEALTHCARE PROFESSIONALS
CAREERS
ABOUT ABBOTT
In a fast-paced keynote interview as part of the health track of this year's virtual CES, Andrea Wainer, Executive Vice President, Rapid and Molecular Diagnostics at Abbott, talks with Michelle Fay Cortez, science and technology reporter for Bloomberg.
What does Wainer see as the state of COVID — and testing — as 2021 gets underway?
"Testing is a critical first-line of defense," she told Cortez. "It needs to be used in context with other hygiene practices of wearing your mask and washing your hands and by no means does this replace that. It comes together along with vaccinations. So, the more you can test, the more you can catch the virus. It's just simple math. Because at any one point in time, anyone can become infected."
For the full interview, click here.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimized for your screen size.